IMAGE: This is professor Richard Morgan, director of the Institute of Cancer Therapeutics at the University of Bradford, UK. view more The drug, known as HRX9, works by preventing the cancer cells from avoiding apoptosis – the natural process by which unhealthy and damaged cells close themselves down and die.
